查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800790

2025 年至 2033 年非侵入性产前检测市场报告（按产品类型、检测类型、技术、方法、应用、最终用户和地区）

Non-Invasive Prenatal Testing Market Report by Product Type, Test Type, Technology, Method, Application, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024年全球非侵入性产前检测市场规模达45亿美元。展望未来， IMARC Group预计到2033年市场规模将达到154亿美元，2025-2033年期间的成长率（CAGR）为13.85%。

非侵入性产前检测 (NIPT) 是一种透过孕妇血液样本进行产前筛检，以检测胎儿是否有异常。此检测主要用于透过分析母亲血液中的 DNA 片段来诊断唐氏症（或 21 三体症）、爱德华兹氏症候群（或 18 三体症）、帕陶氏症候群（或 13 三体症）和特纳氏症等遗传性疾病。此检测无需进行绒毛膜绒毛取样 (CVS) 等各种危险且侵入性的检测，并且可在怀孕九週后进行。

胎儿遗传性疾病的日益普及是推动市场成长的关键因素之一。此外，生命科学和医疗保健产业的技术进步也为市场提供了助力。例如，DNA定序技术、再生医学的发展以及分子研究的突破，为在早期阶段预防任何严重疾病创造了巨大的可能性。此外，产前检测的接受率不断提高，以及公众健康意识的增强以及对此类检测益处和重要性的认识，也推动了市场的成长。医疗保健提供者以及准父母正在采用其他方法来诊断其他遗传性疾病，包括脊柱裂、颚裂和镰状细胞性贫血，并在胎儿发育的早期阶段进行治疗。此外，高龄（35岁或以上）生育的趋势也对市场成长产生了正面影响。产妇年龄增长可能导致多种健康併发症，如高血压、生育能力下降、流产风险以及胎儿染色体异常风险增加。

本报告回答的关键问题

  • 2024年全球无创产前检测市场规模？ 2025-2033年全球非侵入性产前检测市场的预期成长率是多少？
  • 推动全球无创产前检测市场发展的关键因素有哪些？
  • COVID-19 对全球非侵入性产前检测市场有何影响？
  • 根据产品类型，全球非侵入性产前检测市场如何分布？
  • 根据测试类型，全球非侵入性产前检测市场如何分布？
  • 根据技术，全球无创产前检测市场如何分布？
  • 根据方法，全球无创产前检测市场如何分布？
  • 根据应用，全球无创产前检测市场如何分布？
  • 根据最终用户，全球无创产前检测市场是如何分布的？
  • 全球无创产前检测市场的主要区域有哪些？
  • 全球无创产前检测市场的主要公司/参与者有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球无创产前检测市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 耗材
  • 仪器

第七章：市场区隔：依测试类型

  • 马特尔尼 21
  • 和谐
  • 帕纳罗玛
  • 维利菲
  • NIFTY
  • 其他的

第八章：市场区隔：依技术

  • 新一代定序
  • 全基因组定序
  • 其他的

第九章：市场区隔：依方法

  • 超音波检测
  • 生化筛检测试
  • 母体血浆中的游离DNA检测
  • 母体血液检测中的胎儿细胞
  • 其他的

第十章：市场细分：按应用

  • 三体症候群
  • 微缺失症候群
  • 其他的

第 11 章：市场区隔：依最终用户

  • 医院
  • 诊断实验室
  • 其他的

第十二章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 13 章：SWOT 分析

第 14 章：价值链分析

第 15 章：波特五力分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies, Inc.
    • Berry Genetics Inc.
    • BGI Genomics Co. Ltd.
    • Eurofins Scientific Services Limited
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Igenomix
    • Illumina Inc.
    • Laboratory Corporation
    • Natera Inc.
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Yourgene Health plc
Product Code: SR112025A2086

The global non-invasive prenatal testing market size reached USD 4.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.4 Billion by 2033, exhibiting a growth rate (CAGR) of 13.85% during 2025-2033.

Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman's blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother's blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus.

Key Market Segmentation:

Breakup by Product Type:

  • Consumables
  • Instruments

Breakup by Test Type:

  • Materni 21
  • Harmony
  • Panaroma
  • Verifi
  • NIFTY
  • Others

Breakup by Technology:

  • NGS
  • WGS
  • Others

Breakup by Method:

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests
  • Fetal Cells in Maternal Blood Tests
  • Others

Breakup by Application:

  • Trisomy
  • Microdeletion Syndrome
  • Others

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the top non invasive prenatal testing companies key players being Agilent Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F. Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc.

Key Questions Answered in This Report

  • 1.What was the size of the global non-invasive prenatal testing market in 2024?
  • 2.What is the expected growth rate of the global non-invasive prenatal testing market during 2025-2033?
  • 3.What are the key factors driving the global non-invasive prenatal testing market?
  • 4.What has been the impact of COVID-19 on the global non-invasive prenatal testing market?
  • 5.What is the breakup of the global non-invasive prenatal testing market based on the product type?
  • 6.What is the breakup of the global non-invasive prenatal testing market based on the test type?
  • 7.What is the breakup of the global non-invasive prenatal testing market based on the technology?
  • 8.What is the breakup of the global non-invasive prenatal testing market based on the method?
  • 9.What is the breakup of the global non-invasive prenatal testing market based on the application?
  • 10.What is the breakup of the global non-invasive prenatal testing market based on the end-user?
  • 11.What are the key regions in the global non-invasive prenatal testing market?
  • 12.Who are the key companies/players in the global non-invasive prenatal testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Non-Invasive Prenatal Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Materni 21
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Harmony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Panaroma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Verifi
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 NIFTY
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 NGS
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 WGS
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Method

  • 9.1 Ultrasound Detection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Screening Tests
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Fetal Cells in Maternal Blood Tests
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Trisomy
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Microdeletion Syndrome
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Diagnostic Laboratories
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies, Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Berry Genetics Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BGI Genomics Co. Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Eurofins Scientific Services Limited
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 GE Healthcare
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Igenomix
      • 16.3.7.1 Company. Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Illumina Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Laboratory Corporation
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Natera Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Perkinelmer Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Yourgene Health plc
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2024
  • Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2024
  • Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2024
  • Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
  • Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
  • Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million USD), 2025-2033
  • Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 9: Global: Non-Invasive Prenatal Testing Market Structure
  • Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players